Trial Search Results
Molecular Analysis of Breast Cancer
This is a research-based study that is looking at the biologic features of breast tissue, lymph node tissue, or blood in order to study breast cancer development growth, and spread. Through tissue and/or blood samples we hope to gain further knowledge and understanding of how to improve diagnosis and treatment of breast cancer by identifying the molecular markers that predict clinical outcome and response to therapy.
Stanford is currently not accepting patients for this trial.
Collaborator: National Institutes of Health (NIH)
- Procedure: breast tissue, lymph node tissue or blood
Inclusion Criteria:People eligible for this study include anyone older than 18 years who is
undergoing one of the following procedures: core needle or surgical breast biopsy,
lumpectomy, mastectomy, axillary lymph node surgery, breast reduction surgery, or ductal
lavage or ductoscopy. Patients who have had breast cancer in the past who are currently
free of disease or who have a breast cancer recurrence are also eligible. All patients who
participate must be able to understand and sign the informed consent. Although most
patients will be female, any males undergoing the above procedures are also eligible for
this study. Exclusion Criteria:Any patient who is less than 18 years old, who is unable to
understand the informed consent, or not undergoing the above procedures will be excluded
from this research.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study